{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:22:01Z","timestamp":1757611321072,"version":"3.44.0"},"reference-count":29,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T00:00:00Z","timestamp":1699488000000},"content-version":"unspecified","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008005","name":"Yonsei University College of Medicine","doi-asserted-by":"publisher","award":["2023-32-0043"],"award-info":[{"award-number":["2023-32-0043"]}],"id":[{"id":"10.13039\/501100008005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2023,10,19]]},"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Data from a decade ago have shown that patients with systemic sclerosis (SSc) have a higher risk of kidney failure than the general population. However, as the incidence of kidney failure due to SSc has been declining, the comparative risk of kidney failure between patients with SSc and the general population could have changed over time. We investigated the risk of kidney failure in patients with SSc compared with the general population, up to more recent years.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This was a nationwide population-based study using the Korean National Health Insurance Service database. Patients with claims data for SSc between 2010 and 2017 (n=2591) and 1:5 age-matched and sex-matched controls (n=12\u2009955) were selected. The index date was the earliest date of claim for SSc between 2010 and 2017. The follow-up duration was from the index date to 2019. The adjusted HRs (aHRs) and 95% CI for kidney failure were estimated using multivariable Cox proportional hazard models.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Over 5.2\u00b12.6 years, the incidence rates of kidney failure in patients with SSc and controls were 2.88 and 0.35 per 1000 person-years, respectively. Patients with SSc had a significantly higher risk of kidney failure than controls (aHR=7.244, 95% CI=4.256 to 12.329). The effect size was larger in patients diagnosed with SSc between 2014 and 2017 (aHR=9.754, 95% CI=3.254 to 29.235) than in those diagnosed before 2010 (aHR=6.568, 95% CI=2.711 to 15.571) or between 2010 and 2013 (aHR=6.553, 95% CI=2.721 to 15.781).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The risk of kidney failure remains higher in patients with SSc than in the general population.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/rmdopen-2023-003490","type":"journal-article","created":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T10:27:37Z","timestamp":1699525657000},"page":"e003490","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Risk of kidney failure in patients with systemic sclerosis: a nationwide population-based study"],"prefix":"10.1136","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7962-3697","authenticated-orcid":false,"given":"Oh Chan","family":"Kwon","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea (the Republic of)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyungdo","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Statistics and Actuarial Science, Soongsil University, Seoul, Korea (the Republic of)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Chan","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea (the Republic of)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,11,9]]},"reference":[{"key":"2025090312371921000_9.4.e003490.1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","article-title":"Systemic sclerosis","volume":"401","author":"Volkmann","year":"2023","journal-title":"Lancet"},{"key":"2025090312371921000_9.4.e003490.2","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41584-023-00909-5","article-title":"State-of-the-art evidence in the treatment of systemic sclerosis","volume":"19","author":"Pope","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"2025090312371921000_9.4.e003490.3","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e3283588dcf"},{"key":"2025090312371921000_9.4.e003490.4","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1159\/000507886","article-title":"Renal involvement in systemic sclerosis: an update","volume":"45","author":"Chrabaszcz","year":"2020","journal-title":"Kidney Blood Press Res"},{"key":"2025090312371921000_9.4.e003490.5","doi-asserted-by":"crossref","DOI":"10.1093\/rap\/rkaa083","article-title":"Exploring molecular pathology of chronic kidney disease in systemic sclerosis by analysis of urinary and serum proteins","volume":"5","author":"Stern","year":"2021","journal-title":"Rheumatol Adv Pract"},{"key":"2025090312371921000_9.4.e003490.6","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.180582"},{"key":"2025090312371921000_9.4.e003490.7","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s12016-022-08945-x","article-title":"Renal disease and systemic sclerosis: an update on scleroderma renal crisis","volume":"64","author":"Cole","year":"2023","journal-title":"Clin Rev Allergy Immunol"},{"key":"2025090312371921000_9.4.e003490.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2014.12.001"},{"key":"2025090312371921000_9.4.e003490.9","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfs317"},{"key":"2025090312371921000_9.4.e003490.10","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq861"},{"key":"2025090312371921000_9.4.e003490.11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/03009742.2021.1917143","article-title":"Increased risk of end-stage renal disease in patients with systemic sclerosis","volume":"51","author":"Lin","year":"2022","journal-title":"Scand J Rheumatol"},{"key":"2025090312371921000_9.4.e003490.12","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ekir.2017.09.003","article-title":"End-stage kidney disease from scleroderma in the United States, 1996 to 2012","volume":"3","author":"Sexton","year":"2018","journal-title":"Kidney Int Rep"},{"key":"2025090312371921000_9.4.e003490.13","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2017.32.5.718"},{"key":"2025090312371921000_9.4.e003490.14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-15436-8","article-title":"Effects of immune-mediated inflammatory diseases on cardiovascular diseases in patients with type 2 diabetes: a nationwide population-based study","volume":"12","author":"Kwon","year":"2022","journal-title":"Sci Rep"},{"key":"2025090312371921000_9.4.e003490.15","doi-asserted-by":"crossref","unstructured":"Kwon OC , Kim Y , Chun J , et al . n.d. Association of immune-mediated inflammatory diseases with depression and anxiety in patients with type 2 diabetes: A nationwide population-based study. Front Med;10. doi:10.3389\/fmed.2023.1103911","DOI":"10.3389\/fmed.2023.1103911"},{"key":"2025090312371921000_9.4.e003490.16","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1111\/bjd.15838","article-title":"Incidence, prevalence, mortality and causes of death in systemic sclerosis in Korea: a nationwide population-based study","volume":"178","author":"Kang","year":"2018","journal-title":"Br J Dermatol"},{"key":"2025090312371921000_9.4.e003490.17","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.117.309803"},{"key":"2025090312371921000_9.4.e003490.18","doi-asserted-by":"crossref","DOI":"10.1093\/rap\/rky041","article-title":"Risk factors for the development of systemic sclerosis: a systematic review of the literature","volume":"2","author":"Abbot","year":"2018","journal-title":"Rheumatol Adv Pract"},{"key":"2025090312371921000_9.4.e003490.19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56113-7","article-title":"Smoking and risk of incident end-stage kidney disease in general population: A nationwide population-based cohort study from Korea","volume":"9","author":"Choi","year":"2019","journal-title":"Sci Rep"},{"key":"2025090312371921000_9.4.e003490.20","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9613062","article-title":"Risk factors for progression of CKD with and without diabetes","volume":"2022","author":"Zhang","year":"2022","journal-title":"J Diabetes Res"},{"key":"2025090312371921000_9.4.e003490.21","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2008.605"},{"key":"2025090312371921000_9.4.e003490.22","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2012.117"},{"key":"2025090312371921000_9.4.e003490.23","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(84)90986-0"},{"key":"2025090312371921000_9.4.e003490.24","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103330","article-title":"Renal involvement in systemic sclerosis","volume":"22","author":"Scheen","year":"2023","journal-title":"Autoimmun Rev"},{"key":"2025090312371921000_9.4.e003490.25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00863.x"},{"key":"2025090312371921000_9.4.e003490.26","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-1-200601030-00006"},{"key":"2025090312371921000_9.4.e003490.27","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2007.08.011"},{"key":"2025090312371921000_9.4.e003490.28","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.8.923"},{"key":"2025090312371921000_9.4.e003490.29","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1111\/j.1523-1755.2005.09916.x","article-title":"Dyslipidemia and the progression of renal disease in chronic renal failure patients","volume":"68","author":"Cases","year":"2005","journal-title":"Kidney International"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2023-003490","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T19:37:30Z","timestamp":1756928250000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2023-003490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":29,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,11,9]]},"published-print":{"date-parts":[[2023,11]]}},"alternative-id":["10.1136\/rmdopen-2023-003490"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2023-003490","relation":{},"ISSN":["2056-5933"],"issn-type":[{"type":"electronic","value":"2056-5933"}],"subject":[],"published":{"date-parts":[[2023,11]]}}}